Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$9.31B |
| 2 |
Apple
AAPL
|
+$8.69B |
| 3 |
Amazon
AMZN
|
+$4.42B |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$4.04B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$3.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.31B |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$1.04B |
| 3 |
Philip Morris
PM
|
+$722M |
| 4 |
Veeva Systems
VEEV
|
+$608M |
| 5 |
Snap
SNAP
|
+$578M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Healthcare | 11.56% |
| 3 | Financials | 9.35% |
| 4 | Consumer Discretionary | 7.77% |
| 5 | Communication Services | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5551
Meridian
MRBK
$234M
| $268K | ﹤0.01% |
17,714
-182
| -1% | -$2.83K |
|
|
PCF
5552
High Income Securities Fund
PCF
$99.9M
| $268K | ﹤0.01% |
36,839
+1,967
| +6% | +$15.1K |
|
5553
Velocity Financial
VEL
$729M
| $268K | ﹤0.01% |
24,315
+166
| +0.7% | +$1.76K |
|
5554
BlackRock Virginia Muni Bond Trust
BHV
$20.3M
| $267K | ﹤0.01% |
21,386
+6,000
| +39% | +$84.9K |
|
5555
Wave Life Sciences
WVE
$1.2B
| $267K | ﹤0.01% |
82,618
-26,887
| -25% | -$51.7K |
|
5556
Zevia
ZVIA
$111M
| $266K | ﹤0.01% |
94,837
-120,714
| -56% | -$374K |
|
5557
American Outdoor Brands
AOUT
$157M
| $265K | ﹤0.01% |
27,758
+13,445
| +94% | +$159K |
|
5558
Taysha Gene Therapies
TSHA
$1.89B
| $265K | ﹤0.01% |
71,651
-104,104
| -59% | -$413K |
|
5559
Direxion Daily FTSE China Bear 3X ETF
YANG
$89.2M
| $265K | ﹤0.01% |
1,213
+653
| +117% | +$208K |
|
5560
Aprea Therapeutics
APRE
$8.05M
| $264K | ﹤0.01% |
17,592
+5,245
| +42% | +$121K |
|
5561
Innovator US Equity Ultra Buffer ETF October
UOCT
$181M
| $264K | ﹤0.01% |
10,000
-327
| -3% | -$8.92K |
|
|
GATO
5562
DELISTED
Gatos Silver, Inc.
GATO
| $264K | ﹤0.01% |
91,985
+36,744
| +67% | +$129K |
|
|
JOAN
5563
DELISTED
JOANN, Inc. Common Stock
JOAN
| $264K | ﹤0.01% |
34,110
+3,614
| +12% | +$33.1K |
|
5564
Wrap Technologies
WRAP
$104M
| $263K | ﹤0.01% |
141,471
-19,539
| -12% | -$46.3K |
|
|
THRN
5565
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $263K | ﹤0.01% |
54,348
+42,162
| +346% | +$256K |
|
5566
Bioventus
BVS
$1.19B
| $262K | ﹤0.01% |
38,616
+7,235
| +23% | +$73.8K |
|
5567
ProShares Ultra S&P500
SSO
$8.41B
| $261K | ﹤0.01% |
11,652
-3,418
| -23% | -$91.6K |
|
|
ASXC
5568
DELISTED
Asensus Surgical, Inc.
ASXC
| $261K | ﹤0.01% |
655,182
-1,064,156
| -62% | -$475K |
|
5569
Celularity
CELU
$20.3M
| $260K | ﹤0.01% |
7,667
+2,679
| +54% | +$218K |
|
5570
Stratus Properties
STRS
$154M
| $260K | ﹤0.01% |
8,090
+2,183
| +37% | +$85.6K |
|
|
TPGY
5571
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
| $260K | ﹤0.01% |
26,218
-6,186
| -19% | -$61.2K |
|
|
NAGE
5572
Niagen Bioscience
NAGE
$247M
| $259K | ﹤0.01% |
155,282
+72,601
| +88% | +$142K |
|
5573
Entrada Therapeutics
TRDA
$267M
| $258K | ﹤0.01% |
21,185
+12,824
| +153% | +$97.3K |
|
|
UXIN
5574
Uxin Ltd
UXIN
$282M
| $258K | ﹤0.01% |
6,158
+2,377
| +63% | +$142K |
|
|
SEEL
5575
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $258K | ﹤0.01% |
99
+3
| +3% | +$7.81K |
|
Similar funds
Morgan Stanley's Q2 2022 Portfolio in Review
As of Q2 2022, Morgan Stanley held 8,351 positions worth $770B, up 3.9% from $741B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley deployed $170B of net new capital in Q2 2022, opening 166 new positions and adding to 4,644 existing holdings. Its largest new stake was Goldman Sachs Future Planet Equity ETF: 2,930,007 shares worth $84M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $3.31B trimmed.
- Morgan Stanley's largest Q2 2022 buy was Goldman Sachs Future Planet Equity ETF: 2,930,007 shares worth $84M.
- Morgan Stanley added most to Microsoft in Q2 2022, an estimated $9.31B increase.
- Morgan Stanley's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.31B.
- Morgan Stanley fully exited BP Midstream Partners LP Common Units representing Limited Partner Interests in Q2 2022, selling an estimated $156M.
- Morgan Stanley's ten largest holdings make up 16% of its $770B portfolio in Q2 2022.
- Morgan Stanley opened 166 new positions and closed 325 in Q2 2022.
- Morgan Stanley's portfolio value rose 3.9% quarter-over-quarter to $770B.
Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.